Company / Free Cash Flow
ANI Pharmaceuticals, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$171.4M
FY2025
5-year range
-$40.1M / $171.4M
FY2021-FY2025
Trend
+258.7%
vs FY2024
Sector context
#36 of 194
Health Care
What the data says
Free Cash Flow changed +259% YoY in FY2025, a notable deviation from the 9-year average annual change of -537%.
Based on SEC 10-K filings.
$171M in FY2025 with a 5-year CAGR of +79.8%. Top quartile in the Health Care sector.
Improved from $110M to $171M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +79.8%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 194This company $171.4M Sector average $470.6M
▼
-63.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +79.8%, indicating consistent growth.
- In FY2025, free cash flow increased 258.7% year-over-year.
- Ranks #36 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $171.4M | +258.7% |
| FY2024 | $47.8M | -56.6% |
| FY2023 | $110.1M | +374.7% |
| FY2022 | -$40.1M | -5339.1% |
| FY2021 | $765.0K | -91.6% |
| FY2020 | $9.1M | -76.6% |
| FY2019 | $39.0M | -36.4% |
| FY2018 | $61.3M | +111.1% |
| FY2017 | $29.1M | +26.8% |
| FY2016 | $22.9M | +503.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026